Federico Martini

Federico Martini

Auto-generated profile, based on publicly available information

Federico Martini

Laboratory of Cellular Immunology, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S., Rome, Italy

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ECEleonora Cimini
Eleonora Cimini
CBCécile Bonnafous
Cécile Bonnafous
VBVeronica Bordoni
Veronica Bordoni
ELEleonora Lalle
Eleonora Lalle
HSHelene Sicard
Helene Sicard
CAChiara Agrati
Chiara Agrati
In chronic HCV infection, treatment failure and defective host immune response highly demand improved therapy strategies. Vγ9Vδ2 T-cells may inhibit HCV replication in vitro through IFN-γ release after Phosphoantigen (PhAg) stimulation. The aim of our work was to analyze Vγ9Vδ2 T-cell functionality during chronic HCV infection, studying the role of IFN-α on their function capability. IFN-γ production by Vγ9Vδ2 T-cells was analyzed in vitro in 24 HCV-infected patients and 35 healthy donors (HD) after PhAg stimulation with or without IFN-α. The effect of in vivo PhAg/IFN-α administration on plasma IFN-γ levels was analyzed in M. fascicularis monkeys. A quantitative analysis of IFN-γ mRNA level and stability in Vγ9Vδ2 T-cells was also evaluated. During chronic HCV infection, Vγ9Vδ2 T-cells showed an effector/activated phenotype and were significantly impaired in IFN-γ production. Interestingly, IFN-α was able to improve their IFN-γ response to PhAg both in vitro in HD and HCV-infected patients, and in vivo in Macaca fascicularis primates. Finally, IFN-α increased IFN-γ-mRNA transcription and stability in PhAg-activated Vγ9Vδ2 T-cells. Altogether our results show a functional impairment of Vγ9Vδ2 T-cells during chronic HCV infection that can be partially restored by using IFN-α. A study aimed to evaluate the antiviral impact of PhAg/IFN-α combination may provide new insight in designing possible combined strategies to improve HCV infection treatment outcome.

1 March 2011 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
PPPaola Paci
Paola Paci
FMFederico Martini
Federico Martini
MBMassimo Bernaschi
Massimo Bernaschi
GDGianpiero D'OFfizi
Gianpiero D'OFfizi
FCFilippo Castiglione
Filippo Castiglione
When to initiate antiretroviral therapy in HIV infected patients is a diffcult clinical decision. Actually, it is still a matter of discussion whether early highly active antiretroviral therapy (HAART) during primary HIV infection may influence the dynamics of the viral rebound, in case of therapy interruption, and overall the main disease course.

1 December 2013 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
VBVeronica Bordoni
Veronica Bordoni
MBMichele Bibas
Michele Bibas
DVDomenico Mlt Viola
Domenico Mlt Viola
ASAlessandra Sacchi
Alessandra Sacchi
CAChiara Agrati
Chiara Agrati
FMFederico Martini
Federico Martini
HIV infection affects dendritic cells (DCs) number, maturation, and function although the cause remains largely unknown. Purified CD34+ hematopoietic progenitor cells (HPCs) obtained from bone marrow of chronic HIV-infected patients were investigated for the differentiative capability toward mature DCs. HIV, although not in active replication, was found able to impair CD34+ HPC differentiation into mature DCs. These results suggest that DCs impairment found in HIV-infected patients may be related to a failure by bone marrow CD34+ HPCs to produce an adequate number of DCs.

18 March 2011
Verified
Journal Article
Closed access
CAChiara Agrati
Chiara Agrati
GDGianpiero D'offizi
Gianpiero D'offizi
MGMarie-Lise Gougeon
Marie-Lise Gougeon
MMMiroslav Malkovsky
Miroslav Malkovsky
ASAlessandra Sacchi
Alessandra Sacchi
FMFederico Martini
Federico Martini

29 March 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
VBVeronica Bordoni
Veronica Bordoni
CAChiara Agrati
Chiara Agrati
ARAlessandra Rinaldi
Alessandra Rinaldi
DVDomenico Viola
Domenico Viola
GSGabriele De Simone
Gabriele De Simone
FMFederico Martini
Federico Martini

1 October 2005 in Current Protocols in Cytometry
Verified
Journal Article
Open access
PDF file
DHDouglas Horejsh
Douglas Horejsh
FMFederico Martini
Federico Martini
MCMaria Capobianchi
Maria Capobianchi
Molecular beacons are single‐stranded nucleic acid structures with a terminal fluorophore and a distal, terminal quencher. These molecules are typically used in real‐time PCR assays, but have also been conjugated with solid matrices. This unit describes protocols related to molecular beacon–conjugated beads (BeadCons), whose specific hybridization with complementary target sequences can be resolved by cytometry. Assay sensitivity is achieved through the concentration of fluorescence signal on discrete particles. By using molecular beacons with different fluorophores and microspheres of different sizes, it is possible to construct a fluid array system with each bead corresponding to a specific target nucleic acid. Methods are presented for the design, construction, and use of BeadCons for the specific, multiplexed detection of unlabeled nucleic acids in solution. The use of bead‐based detection methods will likely lead to the design of new multiplex molecular diagnostic tools.